Phase II Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer-Reference-Cited by-同舟云学术

Phase II Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer

Published:2005 Issue:1 Volume:69 Page:88-95
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Yeh Kun-Huei,Lu Yen-Shen,Hsu Chih-Hung,Lin Jing-Fang,Hsu Chiun,Kuo Sung-Hsin,Li Shiou-Jr,Cheng Ann-Lii

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference53 articles.

1. Ho D: Epidemiologic studies in gastric cancer; in Ho D (ed): Gastric Cancer. New York, Churchill Livingstone, 1988, pp 1-25.

2. The epidemiology of gastric cancer

3. Chemotherapy of carcinoma of the stomach

4. The Role of Chemotherapy in the Management of Gastric Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Awardee Summary of 2023 Taiwan Oncology Society Clinical Research Award Recipient: Persistent Endeavors on Research of Digestive Cancers for Three Decades;Journal of Cancer Research and Practice;2024-01

2. The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study;BMC Cancer;2022-11-28

3. Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer;Anti-Cancer Drugs;2019-03

4. Retrospective study on efficacy of a paclitaxel combined with a leucovorin and fluorouracil regimen for advanced gastric cancer;Tumori Journal;2018-08-29

5. The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer;Medicine;2014-11